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Abstract
Objectives—Age-at-menopause and leukocyte telomere length (LTL) are both associated with 
biologic aging. Therefore, it would be reasonable to hypothesize that LTL may also serve as a 
marker for reproductive aging as shorter LTL may be associated with earlier age-at-menopause.
Methods—We analyzed data from 799 post-menopausal (ages 41–85) participants in the 
National Health and Nutrition Examination Survey (1999–2002), a nationally representative 
sample of U.S. women.
Results—Controlling for behavioral, socio-demographic, and health-related determinants of 
menopause, we found that among non-Hispanic white women, an increase of one standard 
deviation in LTL was associated with a 0.43 year higher reported age-at-menopause. Among 
Mexican–Americans, an increase of one standard deviation in LTL was associated with a 1.56 
year earlier menopause. There was no significant association between LTL and age-at-menopause 
among non-Hispanic black women.
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Conclusions—Our main finding is evidence of a strong interaction by race/ethnicity in the 
association between LTL and age-at-menopause. This evidence does not support the hypothesis 
that shorter LTL is a predictor of earlier age-at-menopause, as the magnitude and direction of the 
associations between LTL and age-at-menopause varied across racial/ethnic groups.
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1. Introduction
Age-at-menopause can be viewed as an index of biologic aging [1,2], the evidence for this 
assertion is found in the association between early reproductive senescence and onset of age-
related morbidities [3–7] as well as early mortality [8–12]. Biologic aging is, in essence, 
cellular functional decline that leads to tissue dysfunction and eventually mortality; and 
leukocyte telomere length (LTL) is a mechanism of this functional decline [13,14]. By 
capping the ends of chromosomes, telomeres protect against chromosomal degradation and 
breakdown. However, telomeres’ protective function declines as they shorten with each 
round of cell division; likelihood of cellular senescence and apoptosis increases as the 
average telomere length decreases [13]. Given that both age-at-menopause and LTL are 
associated with biologic aging it would be reasonable to hypothesize that LTL may also 
serve as a marker for reproductive aging as shorter LTL may be associated with earlier age-
at-menopause. Examination of the link between LTL and age- at-menopause, independent of 
behavioral, socio-demographic, and health-related determinants of menopause, can 
potentially also provide a biologic explanation for the differing rates of reproductive aging 
observed among women.
To date, three studies have specifically focused on the link between LTL and age-at-
menopause. Among a Turkish convenience sample (n = 37) of healthy women aged 50, 
crude bivariate analyses revealed menstruating women to have longer LTL than menopausal 
women [15]. Two other studies, one of Caucasian post-menopausal women at risk of 
cognitive decline (n = 53; age: 49–69), and the other of Caucasian women participating in 
the Cardiovascular Health Study (n = 486; age: 64–80+), found a positive association 
between LTL and age-at-menopause [16,17]. However, only the latter study controlled for 
confounders of this association. Two case-control studies of Caucasian cancer patients, both 
nested within Nurses’ Health Study, included age-at-menopause as a confounder, neither 
study found an association between LTL and age-at-menopause [18,19].
We addressed some limitations of existing studies, specifically their relatively small sample 
sizes and exclusive reliance on Caucasian populations, by examining the link between LTL 
and age-at-menopause among a diverse sample of postmenopausal women drawn from the 
National Health and Nutrition Examination Survey (NHANES: 1999–2002), a large, 
nationally representative, sample of the civilian, non-institutionalized US population. We 
also examined whether the association between LTL and age-at-menopause is consistent 
among different racial-ethnic groups. This inquiry was motivated by a report of such effect 
modification by Gray et al. [17] (which led them to focus their investigation on Caucasian 
women) and by evidence of racial/ethnic differences in rates of telomere shortening with age 
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[15], with reports of both longer [14,20–22] and shorter [23,24], LTL among historically 
disadvantaged populations.
2. Methods
2.1. Study population
Data were from 1999 to 2002 National Health and Nutrition Examination Survey 
(NHANES), a cross-sectional survey of the civilian, non-institutionalized US population (0–
85 years of age) conducted continuously in 2-year survey cycles [25]. The NHANES uses a 
multistage probability sampling design, with some subgroups oversampled (e.g., low-
income white persons). Unweighted response rates for the total examined female sample 
range from 77% to 80% for the survey cycles covering 1999–2002, the only NHANES 
cycles for which telomere data are available [26].
The analytic sample was drawn from the 2129 women, ages 30–85 years who completed the 
mobile examination component (MEC) and had LTL data available, who were not pregnant 
or lactating, and responded negatively to the question “Have you had regular periods in the 
past 12 months?” Women with a history of hysterectomy, unilateral/bilateral oophorectomy, 
or who reported their menopause status as attributable to other medical conditions or 
treatments, or reported chronic oligomenorrhea/amenorrhea were also excluded from our 
analytic sample (n = 1059), but reserved for a subsequent sensitivity analyses. Of the 
eligible sample of 1070 potentially postmenopausal women, 254 were excluded due to 
missing data for age-at-menopause or information about medical/surgical history. 
Additionally, women who reported to have undergone menopause before age 30 or after age 
60 were excluded from the analytic sample (n = 17), consistent with prior studies that had 
used these thresholds to rule out implausible values [17], leaving a final analytic sample of 
799 (75%) women ages 41–85 years (Supplemental Fig. 1).
2.2. Measures
Age-at-menopause was defined based on the question “About how old were you when you 
had your last menstrual period?” with responses in years. Telomere length assay is detailed 
elsewhere [14]. Briefly, DNA was extracted from whole blood and stored at −80°. LTL was 
assayed using the quantitative polymerase chain reaction method to measure telomere length 
relative to standard reference DNA (T/S ratio) [16]. The single-copy gene used as a control 
to normalize input DNA was human beta-globin. Each sample was assayed 3 times on 3 
different days. The samples were assayed on duplicate wells, resulting in 6 data points. 
Sample plates were assayed in groups of 3 plates, and no 2 plates were grouped together 
more than once. Each assay plate contained 96 control wells with 8 control DNA samples. 
Assay runs with 8 or more invalid control wells were excluded from further analysis (<1% 
of runs). Control DNA values were used to normalize between-run variability. Runs with 
more than 4 control DNA values falling outside 2.5 standard deviations from the mean for 
all assay runs were excluded from further analysis (<6% of runs). For each sample, any 
potential outliers were identified and excluded from the calculations (<2% of samples). The 
mean and standard deviation of the T/S ratio were then calculated normally. The interassay 
coefficient of variation was 6.5%. Finally, it is noteworthy that observed LTL length can 
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vary across laboratories and types of assays. While these values tend to be highly correlated, 
they can have different means [27].
Demographic characteristics were collected during the NHANES household interview. All 
models included age (as a linear variable) and race/ethnicity (non-Hispanic white, non-
Hispanic black, Mexican–American and other). However, because the group of participants 
identified as belonging to “other” races/ethnicities is small and heterogeneous, results are 
not presented for this group, though they were included in the analytic sample. We also 
controlled for key determinants of age-at-menopause and LTL: reported lifetime smoking 
(never, former, current [28,29]; body mass index (BMI) [29,30], and household income to 
poverty ratio as a proxy for individual-level SES. Additional covariates were included as 
prior work had reported associations with age-at-menopause [17,31]: gravidity (nulligravid 
or not), marital status (single/never married, married/cohabitating, divorced/widowed/
separated), and reported history of cardiovascular disease (i.e., coronary heart disease, 
stroke, congestive heart failure, angina, or heart attack) [17]; or cancer. Finally, to control 
for the lapsed time between occurrence of menopause and when blood samples were drawn, 
age-at-interview, which was when the blood was drawn, was also included as a linear 
variable. Missing data on these covariates further reduced the sample to 635 women for fully 
adjusted models (Table 1).
2.3. Analyses
We fit a series of linear regression models to estimate the association between LTL 
(independent variable) and age-at-menopause (dependent variable) and corresponding 95% 
confidence intervals (CIs). LTL was log-transformed for normality, as it was positively 
skewed. The first model included only age and race/ethnicity in addition to LTL. To explore 
potential differences by race/ethnicity in the associations between LTL and age-at-
menopause, the second model added an interaction term between LTL and race/ethnicity, as 
there is evidence that LTL may differ by race/ethnicity [14,17,20,21,23,24]. The third model 
included all socio-demographic and health-related covariates noted above.
A sensitivity analysis examined LTL in relation to age-at-menopause among women who 
reported surgical or medical menopause; this analysis was conducted as a falsification test as 
age-at-menopause among this sample should be unrelated to LTL. MEC sample weights 
were used to account for differential probabilities of selection, non response and non-
coverage; and survey procedures in Stata 12.1 SE were used to account for the complex 
survey design of NHANES. Standard errors and Wald 95% CIs were estimated using Taylor 
series linearization, with p < 0.05 indicating statistical significance.
Finally, sensitivity analyses replicated the model building process described above, but 
utilized multiply imputed data sets for age-at-menopause for the sample of 1070 post-
menopausal women (and 844 women with medical/surgical menopause) to mitigate the 
impact of missing data. These analyses are fully described in Supplemental Appendix.
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3. Results
Descriptive characteristics of postmenopausal women in the U.S. appear in Table 1. For 
comparison, characteristics of women meeting eligibility criteria but reporting menopause 
attributable to surgery or medical reasons (e.g., hysterectomy, oophorectomy) are also 
presented. Women were, on average, 63 years old (95% CI: 62.48–64.42 years), 
significantly older than the comparable sample of women who had a history of surgical or 
medically attributable menopause (60.42 years, 95% CI: 59.02–61.82). The mean age-at-
menopause was 48.88 years (95% CI: 48.59–48.18); again, significantly older than women 
in the surgical/medical menopause group (40.58, 95% CI: 39.92–41.24). Most women were 
non-Hispanic white (79%) with 7% non-Hispanic black and 4% Mexican–American. 
Mexican–American women were younger, on average, than white women (p < 0.01). They 
also reported younger age-at-menopause (p = 0.03), and had a shorter time between their 
current attained age and their reported-age-atmenopause than white women (p < 0.01). 
There were no significant differences between the various age-related variables comparing 
Mexican–American women and non-Hispanic black women. Finally, the mean LTL 
(adjusted for age) was 1.11 (95% CI: 1.02–1.19) for non-Hispanic white women, 1.15 (95% 
CI: 1.08–1.23) for non-Hispanic black women, and 1.08 (95% CI: 1.01–1.14) for Mexican–
American women; these latter values were not statistically different from that of non-
Hispanic white women.
Results of the linear regression models are presented in Table 2. Model 1 included only 
LTL, age, and race/ethnicity. None of these covariates were significantly associated with 
ageat- menopause. Model 2 added an interaction term between race/ethnicity and LTL. In 
this model, significant differences were observed by race/ethnicity in the associations 
between LTL and age-at-menopause. For non-Hispanic white women, longer LTL was 
positively associated with age-at-menopause (b = 1.72, 95% CI: 0.04–3.39). For Mexican–
American women, the linear combination of the coefficients for the main and interaction 
effects was calculated and indicated that longer LTL was negatively associated with age-at-
menopause (b = −7.71, 95% CI: −11.49 to −3.93). For non- Hispanic black women, the 
linear combination of terms suggested that there was no association between LTL and age-
at-menopause (b = −0.19, 95% CI: −3.56 to 3.18). The differences by race/ethnicity in the 
associations between LTL and age-at-menopause are presented in Fig. 1.
These patterns were robust to the inclusion of several additional socio-demographic 
characteristics and potential confounders (Model 3). In fully adjusted models, LTL was 
positively associated with age-at-menopause for non-Hispanic white women (b = 1.84, 95% 
CI: 0.23–3.44), while there was a negative association for Mexican–American women (b = 
−7.17, 95% CI: −11.44 to −2.90), and no statistically significant association among non- 
Hispanic black women (b = 2.61, 95% CI: −2.43 to 7.64). Results were also the same for 
models controlling for a history of CVD or cancer, however those results are not shown as 
those two covariates were not associated with age-at-menopause.
Models examining the association between LTL and age-at-menopause among women with 
surgically or medically induced menopause (e.g., hysterectomy, oophorectomy, or other 
conditions or treatments leading to amenorrhea) were run as a falsification test, as there is no 
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expectation that LTL would be related to age-at-menopause in this group. Indeed, there was 
no significant association between LTL and age-at-menopause for any racial/ethnic 
subgroup among women with surgical or medically induced menopause (Table 2).
In sensitivity analyses using the multiply imputed data for ageat- menopause, results were 
similar to the complete-case analysis presented above. The complete results of our 
sensitivity analyses are presented in Supplemental Table 1.
4. Discussion
We conducted the first study of the association between LTL and age-at-menopause among 
a nationally representative sample of postmenopausal US women. This study’s main finding 
is evidence of a strong interaction by race/ethnicity in the association between LTL and age-
at-menopause. Among non-Hispanic white women, an increase of one standard deviation in 
LTL was associated with a 0.43 year higher reported age-at-menopause, independent of a 
variety of potential determinants of menopause. In contrast, among Mexican–American 
women an increase of one standard deviation in LTL was associated with a 1.56 year earlier 
menopause. While non-Hispanic black women evinced a positive association between LTL 
and age-at-menopause, similar to that of white women, this association was not statistically 
significant. We attribute this to inadequate statistical power due to the small sample size of 
postmenopausal non-Hispanic black women and the relatively limited variation in LTL 
among this sample.
To better understand our paradoxical findings among Mexican–American women, we 
considered confounding by factors more prominent in this population that presumably 
includes a larger proportion of immigrants than the two other populations we have 
examined. However, inclusion of variables related to immigration status (e.g., whether the 
participant was born in the US) did not change our findings. Confounding as an explanation 
for this finding is further discounted (but not completely negated) by the fact that the 
negative association between LTL and age-at-menopause does not appear among Mexican–
American women with surgical/medical menopause.
We also considered that some Mexican–American women may have responded to items on 
the reproductive history questionnaire such that they were included in our analytic sample, 
but were not truly postmenopausal (i.e., they may have had oligomenorrhea/amenorrhea but 
did not report it as such). However, results did not change in models that included only 
women whose predominant language was English (data not shown). It is possible that the 
language of interview may have influenced the responses, but that item was not available in 
the public use data file, and presumably reported predominant language would be highly 
related to language of interview. Moreover, the percentage of our analytic sample 
identifying as Mexican–American was similar to that of all women 40 years and older in 
NHANES (3.5% in our analytic sample vs. 4.3% overall). If pre-menopausal Mexican–
American women were inadvertently included in our analytic sample, it might be expected 
that the proportion of Mexican–American women in our analytic sample would be higher 
than for the overall NHANES sample of women over 40, but this was not the case.
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Our findings of a positive association between LTL and age-at-menopause among white 
women is consistent with earlier reports [15–17] and is supportive of the view that LTL is a 
predictor of reproductive aging among this subpopulation. However, this notion is negated 
by evidence of a negative association among Mexican-American women. Gray et al. [17] 
also reported distinct associations between age-at-menopause and LTL by race and 
ethnicity. Among their sample, longer LTL predicted later age-at-menopause among white 
women but earlier age-at-menopause among nonwhite women. Gray et al. attributed their 
findings to chance or potential selection bias. However, there is an accumulating body of 
paradoxical findings related to LTL. In particular, reports of longer LTL among historically 
disadvantaged populations have been made with some regularity [14,20,21] but not without 
reports to the contrary [23,24]. Our findings add to the body of paradoxical findings related 
to LTL.
Our findings are best considered in light of the study’s strengths and weaknesses. Strengths 
of this study include it being the first study conducted among a large, multi-ethnic, sample 
of women representative of non-institutionalized US population. We have controlled for a 
larger number of covariates than has been possible to date and conducted sensitivity and 
post-hoc analyses to confirm our paradoxical findings. Our study’s weakness, emanating 
from its cross-sectional design, is the time span between mean age-at-menopause (49 years) 
and mean age at which blood samples were drawn (63 years). While a reasonable approach 
might be to limit our analyses to a sample of women who were interviewed within 10 years 
after menopause, we lack statistical power to do so. However, we have addressed this issue 
by including age at interview, which was when blood was drawn, as a covariate in the 
regression models. Furthermore, because LTL is at least moderately heritable, we reason 
that LTL measured after menopause is likely a useful marker of LTL prior to menopause 
[17]. It is also noteworthy that observed telomere length can vary across extraction methods 
and types of assays. However, our results are comparable to results from other studies using 
NHANES data and are likely to be similar to other PCR-derived measures of telomere 
length if they used the same methods outlined here and detailed elsewhere [27].
In sum, results presented here did not support the hypothesis that shorter LTL is a predictor 
of earlier age-at-menopause, as the magnitude and direction of the associations between 
LTL and age-at-menopause varied across racial/ethnic groups. Consequently, our findings of 
null or inverse associations for some racial/ethnic subgroups are also inconsistent with the 
notion that LTL is a biologic determinant of reproductive aging.
It has been noted that introduction of molecular data to epidemiologic studies has added, 
rather than reduced, complexity in the analysis of the intertwined effects of social history 
and biologic factors on health [32]. Various subpopulations often occupy different positions 
within the social hierarchy with concomitant distinctions, such as chronicity of exposure to 
stress, which have differential effects on health, even at the cellular level [33]. In the context 
of reports of longer LTL among African Americans or inverse associations between age-at-
menopause and LTL among Mexican–Americans, as was illustrated in this analysis, it 
becomes particularly difficult to disentangle innate biologic differences from differential 
social exposures throughout the life course. Further longitudinal analyses may help clarify 
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the trajectories of biologic differences and the consequences of social exposures across 
racial/ethnic subpopulations.
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Appendix
Multiple imputation methods and results
To examine and mitigate the impact of missing data, age-at-menopause was multiply 
imputed (with values constrained to fall between 30 and 60 years, or current attained age if 
younger than 60) for the sample of 1070 potentially postmenopausal women with missing 
age-at-menopause data. The multiple imputation models used truncated regression to predict 
age-at-menopause based on current age, race/ethnicity and estimated the imputed values 
separately for the subsample of women reporting surgical or medical menopause (i.e., a 
history of hysterectomy, oophorectomy, or other medical conditions or treatments leading to 
oligomenorrhea/ amenorrhea).
Sensitivity analyses were conducted using the 10 multiply imputed data sets. Models 
presented in the main paper were replicated using the multiply imputed data sets for age-at-
menopause for the sample of 1070 post-menopausal women (and 844 women with medical/
surgical menopause) to mitigate the impact of missing data. Models using the 10 multiply 
imputed data sets were fit using the mi commands in Stata 12.1 SE as well as the survey 
procedures.
Results for models using the multiply imputed data sets were largely similar to those using 
the complete-case analysis. Although the association between LTL and age-at-menopause 
was no longer statistically significant among non-Hispanic white women (b = 1.42; 95% CI: 
−0.18 to 3.01, p = 0.079) in the fully adjusted multiply imputed model, the association was 
in the same direction and of generally similar magnitude compared to the complete-case 
analysis. Additionally, this association remained significant in the multiply imputed model 
with only the race/ethnicity by LTL interaction term. All other patterns remained the same 
as in the main analysis. There was a statistically significant interaction between race/
ethnicity and LTL, such that Mexican–American women were different than non-Hispanic 
white women (p = 0.008); the linear combination of terms from this model suggested that 
the association between LTL and age-at-menopause among Mexican–American women 
remained negative and significant (b = −5.54; 95% CI: −10.04 to −1.04, p = 0.018). Similar 
to findings from the main analysis, the linear combination of terms from the model 
suggested that there was no significant association between LTL and age-at-menopause 
among non-Hispanic black women (b = 1.78; 95% CI: −2.15 to 5.71, p = 0.360). Finally, 
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there were no associations between LTL and age-at-menopause among any racial/ethnic 
group in the falsification test models among women with surgical/medical menopause using 
the multiply imputed data (n = 844).
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Fig. 1. 
Associations between LTL and age-at-menopause by race/ethnicity, estimated from fully 
adjusted models with interaction terms between race/ethnicity and LTL.
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